<DOC>
	<DOCNO>NCT01624675</DOCNO>
	<brief_summary>The purpose study evaluate efficacy risperidone compare placebo child adolescent irritability associate autistic disorder .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Risperidone ( R064766 ) Children Adolescents With Irritability Associated With Autistic Disorder</brief_title>
	<detailed_description>This randomize ( drug assign chance ) , 8-week , double-blind ( neither physician patient know treatment patient receives ) , placebo-controlled ( placebo inactive substance compare drug test whether drug real effect clinical trial ) , parallel-group ( group patient treat time ) , flexible-dose , multicenter study . It follow 48-week , flexible-dose , open-label ( people know identity intervention ) extension , evaluate efficacy safety risperidone child adolescent diagnosis autistic disorder ( severe form pervasive developmental disorder ) associate irritability . The study consist 2-week screen phase , 8-week double-blind phase , 48-week open-label phase , 1-week follow-up phase .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnostic autistic disorder A Clinical Global Impression Severity ( CGIS ) score = &gt; 4 Aberrant Behavior Checklist Japanese Version ( ABCJ ) Irritability Subscale score = &gt; 18 Patients mental age &gt; 18 month measure appropriate developmental mental scale Patients appropriate caregiver , eg , parent studysite personnel , able observe patient 's condition , provide information , evaluate patient 's response appropriately Patients previous current psychotic disorder ( eg , schizophrenia , bipolar disorder , psychiatric disorder ) pervasive developmental disorder otherwise specify , Asperger 's disorder , Rett 's disorder , pediatric destructive behavior disorder , substance dependence Patients clinically significant endocrine , metabolic , cardiac , hepatic , renal , pulmonary disorder , hypertension Weight &lt; 15 kg time screen baseline Patients QTc &gt; 450 msec standard 12lead electrocardiogram ( ECG ) time screen Patients know hypersensitivity risperidone paliperidone</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Autistic disorder child adolescent</keyword>
	<keyword>Risperidone ( R064766 )</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Irritability</keyword>
	<keyword>Autistic disorder</keyword>
</DOC>